2019
DOI: 10.1016/j.biomaterials.2019.03.007
|View full text |Cite
|
Sign up to set email alerts
|

Immobilization of nano Cu-MOFs with polydopamine coating for adaptable gasotransmitter generation and copper ion delivery on cardiovascular stents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
63
0
2

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 109 publications
(68 citation statements)
references
References 44 publications
2
63
0
2
Order By: Relevance
“…Furthermore, if Cu ion or complex combined with proteins or its receptor, which will inhibit platelet and cell adhesion to the material's surface. There was a new research on the stent with nano Cu‐MOFs with polydopamine coating, which inhibited thrombosis, intimal hyperplasia, and accelerate re‐endothelialization (Fan et al, 2019). In the platelet adhesion test part, the nano Cu‐MOFs‐immobilized coating exhibited desirable NO release and adaptable Cu 2+ delivery.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, if Cu ion or complex combined with proteins or its receptor, which will inhibit platelet and cell adhesion to the material's surface. There was a new research on the stent with nano Cu‐MOFs with polydopamine coating, which inhibited thrombosis, intimal hyperplasia, and accelerate re‐endothelialization (Fan et al, 2019). In the platelet adhesion test part, the nano Cu‐MOFs‐immobilized coating exhibited desirable NO release and adaptable Cu 2+ delivery.…”
Section: Discussionmentioning
confidence: 99%
“…Inspired by the properties of PDA film, which exhibits strong adhesion to almost any substrate via covalent and/or non‐covalent interactions, [ 117 ] Yajun Weng and colleagues used PDA as the linker and coating matrix to immobilize nanoscale copper‐based MOF onto the titanium surface for simultaneous NO catalytic generation by decomposing endogenous snitrosothiols. [ 118 ] Inhibited platelet aggregation, reduced thrombosis, and promoted EC proliferation were achieved using such coating. However, it is hard to control the amount of endogenous Snitrosothiols around the coating stents, leading to the poor controllability in NO release and suboptimal therapeutic effect of NO.…”
Section: The Biomedical Applications Of Polymeric No Delivery Nanoplamentioning
confidence: 99%
“…For example, the arterial endothelium produces NO, which can induce vasodilation (Olver et al, ). Moreover, NO affects the cardiovascular system by inhibiting platelet activation, anti‐atherosclerotic effects, and SMC proliferation (Fan et al, ). Furthermore, there were many other endothelium‐derived factors, such as PGI2, EDHF, and ET‐1(Figure ), which can affect the function of SMCs (Vanhoutte, ).…”
Section: Discussionmentioning
confidence: 99%